Oppenheimer Reiterates Outperform Rating on CRISPR Therapeutics (CRSP)
Go back to Oppenheimer Reiterates Outperform Rating on CRISPR Therapeutics (CRSP)| (NASDAQ: CRSP) | Delayed: 50.46 -0.17 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.63 | 52 Week High | $18.88 | |||
| Open | $50.56 | 52 Week Low | $13.75 | |||
| Day High | $51.00 | P/E | N/A | |||
| Day Low | $49.33 | EPS | $0.00 | |||
| Volume | 1,726,648 | |||||
